MITHRA PHARMACEUTICALS SA NV NPV revenue breakdown overview

MITHRA PHARMACEUTICALS SA NV NPV revenue for the last year amounted to 40.20 M EUR, the most of which — 67.00 M EUR — came from its highest performing source at the moment, Therapeutic Products, the year earlier bringing 22.67 M EUR. The greatest contribution to the revenue figure was made by Europe — last year it brought MITHRA PHARMACEUTICALS SA NV NPV 51.33 M EUR, and the year before that — 9.29 M EUR.